Search
Xelaglifam
go.drugbank.com/drugs/DB21598InvestigationalXelaglifam has a monoisotopic molecular weight of 501.2 Da. … Xelaglifam is a small molecule drug. Xelaglifam is under investigation in clinical trial NCT04982705 (IDG-16177 for the Evaluation of Its Safety and Pharmacokinetics).
Fulimetibant
go.drugbank.com/drugs/DB21599ExperimentalFulimetibant has a monoisotopic molecular weight of 487.15 Da. … Fulimetibant is a small molecule drug. The usage of the INN stem '-tibant' in the name indicates that Fulimetibant is a bradykinin receptor antagonist.
Adrixetinib
go.drugbank.com/drugs/DB21620InvestigationalAdrixetinib has a monoisotopic molecular weight of 531.17 Da. … Adrixetinib is a small molecule drug. The usage of the INN stem '-tinib' in the name indicates that Adrixetinib is a tyrosine kinase inhibitor.
Friluglanstat
go.drugbank.com/drugs/DB21652ExperimentalFriluglanstat has a monoisotopic molecular weight of 516.12 Da. … Friluglanstat is a small molecule drug. The usage of the INN stem '-glanstat' in the name indicates that Friluglanstat is a prostaglandin synthase inhibitor.
Canlitinib
go.drugbank.com/drugs/DB21656ExperimentalCanlitinib has a monoisotopic molecular weight of 619.21 Da. … Canlitinib is a small molecule drug. The usage of the INN stem '-tinib' in the name indicates that Canlitinib is a tyrosine kinase inhibitor.
Labuxtinib
go.drugbank.com/drugs/DB21658ExperimentalLabuxtinib has a monoisotopic molecular weight of 377.13 Da. … Labuxtinib is a small molecule drug. The usage of the INN stem '-tinib' in the name indicates that Labuxtinib is a tyrosine kinase inhibitor.
Talorasib
go.drugbank.com/drugs/DB21686ExperimentalTalorasib is a small molecule drug. The usage of the INN stem '-rasib' in the name indicates that Talorasib is a Ras protein inhibitor. Talorasib has a monoisotopic molecular weight of 604.24 Da.
Relebactam
go.drugbank.com/drugs/DB12377ApprovedInvestigational[A181195,A181207] It includes a piperidine ring which reduces export from bacterial cells by producing a positive charge. … [label] It is considered to be a last-line treatment option and gained FDA approval as part of the combination product RecarbrioⓇ in July 2019.[L7568]
Ferric pyrophosphate citrate
go.drugbank.com/drugs/DB13995Approved[L1419] It is also FDA approved since 2015.[FDA label] … Ferric pyrophosphate citrate is a soluble iron replacement product.
Zopapogene imadenovec
go.drugbank.com/drugs/DB24672ApprovedInvestigationalFood and Drug Administration (FDA) for the treatment of adults with RRP, receiving full FDA approval on August 15, 2025.[L54081] … [L54081] Zopapogene imadenovec is a non-replicating adenoviral vector–based immunotherapy that expresses a fusion antigen from selected regions of HPV-6/11 proteins to elicit an immune response in RRP.
Synonyms: human cytomegalovirus (CMV) promoter and terminated with a 3' untranslated region and a simian virus 40 (SV40) polyadenylation signal, DNA (recombinant replication-deficient Gorilla gorilla gorilla adenovirus strain GC4 vector PRGN-2012 human cytomegalovirus promoter plus human papillomavirus 6/11 E2, E4, E6, E7 protein 11 epitope-containing